Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (24)
  • 2024 (29)
  • 2023 (54)
  • 2022 (90)
  • 2021 (71)
  • 2020 (10)
  • 2019 (6)
  • 2018 (2)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Press Conferences (68)

Drug Name

  • Fentanyl (64)
  • Opioids (51)
  • Oxycodone (49)
  • Cocaine (23)
  • Methamphetamine (19)
  • Synthetic Opioids (17)
  • Heroin (13)
  • Hydromorphone (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Marijuana (Cannabis) (2)
  • Ecstasy/MDMA (1)
  • GHB (1)

Field Division

  • Washington, DC (55)
  • St. Louis (33)
  • New York (23)
  • Chicago (20)
  • Sede (18)
  • New Jersey (17)
  • Miami (16)
  • El Paso (13)
  • Atlanta (12)
  • Seattle (12)
  • Dallas (11)
  • Houston (9)
  • Rocky Mountain (7)
  • San Francisco (7)
  • New England (6)
  • New Orleans (6)
  • Los Angeles (5)
  • Louisville (5)
  • Omaha (5)
  • San Diego (5)
  • Phoenix (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

Julio 20, 2022
MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
Julio 20, 2022
PRESS RELEASE

Suburban Chicago Physician Charged with Federal Health Care Fraud

Julio 15, 2022
CHICAGO — Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration Chicago Division, and U.S. Attorney John R. Lausch, Jr., for the Northern District of Illinois, announced that a suburban Chicago physician prescribed opioids to patients without a medical examination or visit and then fraudulently billed Medicare...
Julio 15, 2022
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

Julio 12, 2022
ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
Julio 12, 2022
PRESS RELEASE

Collinsville Osteopathic Physician Admits Illegally Prescribing Drug

Julio 07, 2022
ST. LOUIS – An osteopathic physician from Collinsville, Illinois, pleaded guilty in U.S. District Court Tuesday and admitted illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, pleaded guilty in front of U.S. District Judge Ronnie L. White to one count of obtaining a controlled substance by fraud and one...
Julio 07, 2022
PRESS RELEASE

Bonifay Doctor Settles Controlled Substances Act Violations For $130,000

Julio 06, 2022
PENSACOLA, Fla. —Ahmad T. Ismail, 70, of Bonifay, Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $130,000 and surrendering his Drug Enforcement Administration (DEA) registration. The settlement was announced by Jason R. Coody, United States Attorney for the Northern District of Florida...
Julio 06, 2022
PRESS RELEASE

Jury Convicts State Lawmaker of COVID-19 Fraud Scheme at Springfield Health Care Charity

Junio 28, 2022
SPRINGFIELD, Mo. – A Missouri state representative was convicted by a federal trial jury today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and...
Junio 28, 2022
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

Junio 28, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
Junio 28, 2022
PRESS RELEASE

Four People Charged in Multimillion-Dollar Health Care Fraud Scheme to Defraud Amtrak

Junio 23, 2022
NEWARK, N.J. – Three men and one woman were arrested today for participating in a health care fraud scheme to defraud Amtrak by bribing Amtrak employees to allow people to submit fraudulent claims to the Amtrak health insurance plan, U.S. Attorney Philip R. Sellinger announced. Muhammad Mirza, 50, of Cedar...
Junio 23, 2022
PRESS RELEASE

Amherst County Veterinarian Sentenced for Opioid Theft

Junio 22, 2022
LYNCHBURG, Va. – A former veterinarian, who admitted to stealing opioids, was sentenced today to eight months in federal prison. Patrick Gries, 54, of Madison Heights, Virginia, pleaded guilty in January 2022 to one count of adulteration of a drug held for sale after shipment in interstate commerce and one...
Junio 22, 2022
PRESS RELEASE

Newport News Pharmacy Agrees to Pay Civil Penalty under the Controlled Substances Act

Junio 21, 2022
NORFOLK, Va. – Hidenwood Pharmacy, Inc., located in Newport News, and its owner, Anne Hutchens, of Seaport, have agreed to pay $125,000 to settle civil penalty claims stemming from alleged record-keeping violations associated with controlled substances. The government alleged that the Hidenwood Pharmacy failed to comply with various recordkeeping requirements...
Junio 21, 2022
Showing 131 - 140 of 289 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 10
  • Página 11
  • Página 12
  • Página 13
  • Current page 14
  • Página 15
  • Página 16
  • Página 17
  • Página 18
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster